• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Wave Life Sciences Ltd. - Ordinary Shares (NQ:WVE)

12.84 +0.16 (+1.26%)
Streaming Delayed Price Updated: 11:12 AM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Wave Life Sciences Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency
February 02, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
This Director Sold 42,000 Shares of Wave Life Sciences for $630,000. What Investors Should Know About This Biotech Company. ↗
January 14, 2026
This biotech innovator in genetic medicines reported significant insider selling, as disclosed in recent SEC filings. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio
January 12, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
The 2025 Weight-Loss Drug Gold Rush: How Eli Lilly Pulled Ahead, Novo Hit A Snag — And A Swarm Of Biotech Underdogs Are Closing In ↗
December 09, 2025
Via Stocktwits
Wave Life Sciences Stock Rockets 120% After Obesity Drug Shows Deep Fat Reduction, Muscle Gain — Traders See A ‘Blockbuster' Candidate ↗
December 08, 2025
Via Stocktwits
News headline image
Earnings Scheduled For November 10, 2025 ↗
November 10, 2025
 
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session. ↗
January 06, 2026
Via Chartmill
News headline image
Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
In today's session, these stocks are experiencing unusual volume. ↗
December 11, 2025
In today's session, these stocks are experiencing unusual volume. 
Via Chartmill
News headline image
Golden Cross Alert: 3 Stocks With Major Upside Potential ↗
December 10, 2025
Via MarketBeat
News headline image
Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
December 09, 2025
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Why Wave Life Sciences Stock Crushed it Again Today ↗
December 09, 2025
There's nothing like a nearly 150% price gain to garner the attention of investors and analysts. 
Via The Motley Fool
News headline image
Which stocks have an unusual volume on Tuesday? ↗
December 09, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets. 
Via Chartmill
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS® Liver Imaging, Strengthens Capital Efficiency; WVE, TWG, BDRX, FULC Also Active
December 09, 2025
Via AB Newswire
News headline image
Why Structure Therapeutics Stock Doubled and Then Some on Monday ↗
December 08, 2025
The company's investigational GLP-1 treatment performed admirably well in a phase 2b study. 
Via The Motley Fool
News headline image
Why Wave Life Sciences Stock Vaulted 146% Higher on Monday ↗
December 08, 2025
We have an emerging new entrant in the increasingly crowded weight loss drug space. 
Via The Motley Fool
Biggest Stock Movers Today, Dec. 8: CFLT, UL, & More ↗
December 08, 2025
Via The Motley Fool
News headline image
Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
December 08, 2025
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
What's going on in today's session ↗
December 08, 2025
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
December 08, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday. 
Via Chartmill
News headline image
Wondering what's happening in today's pre-market session? ↗
December 08, 2025
Wondering what's happening in Monday's pre-market session? Find an overview in this article. 
Via Chartmill
News headline image
Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss
December 08, 2025
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
December 07, 2025
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
December 03, 2025
December 3, 2025 – Capricor Therapeutics (NASDAQ: CAPR) has sent shockwaves through the biotech sector today, witnessing an astonishing 535% surge in its stock price, propelling the company to an... 
Via MarketMinute
News headline image
These Analysts Revise Their Forecasts On Wave Life Sciences Following Q3 Results ↗
November 11, 2025
 
Via Benzinga
News headline image
Wave Life Sciences (WVE) Earnings Transcript ↗
November 10, 2025
Wave Life Sciences (WVE) Earnings Transcript 
Via The Motley Fool
News headline image
Wave Life Sciences Ltd (NASDAQ:WVE) Reports Q3 2025 Earnings Miss, Stock Falls ↗
November 10, 2025
Wave Life Sciences reported mixed Q3 2025 results, missing on revenue and EPS. Despite the financial miss, the biotech highlighted strong clinical progress for its obesity and AATD programs. 
Via Chartmill
Topics Earnings
News headline image
Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update
November 10, 2025
From Wave Life Sciences USA, Inc.
Via GlobeNewswire
News headline image
Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
November 07, 2025
The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
A Look Ahead: WAVE Life Sciences's Earnings Forecast ↗
November 07, 2025
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap